UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe generalized anxiety ...
Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being approved for the common mental health condition ...
I became a neuroscientist to help us understand how humans gain deeper insight and observation into themselves, life, and being during altered states of consciousness. I never expected to write a post ...
In a recent study published in the journal Translational Psychiatry, researchers from New Zealand conducted a phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on ...
MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
AUSTIN, Texas--(BUSINESS WIRE)--SÄPT today shared new data, presented by researchers this weekend, which showed that long-term efficacy was maintained for almost 2 years among adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback